California-based medical equipment manufacturer Resmed Inc. (RMD) launched a continuous and automatic positive-airway pressure (:PAP) device platform titled “AirSense 10.” The AirSense 10 series PAP ...
Explore how changing treatment trends and industry competition are influencing ResMed’s future outlook, innovation strategy, ...
I initiate coverage of ResMed with a Hold rating, citing dominant OSA positioning but near-term competitive headwinds. RMD’s recurring revenue model leverages device sales, consumables, and SaaS, with ...
“Our first-quarter fiscal year 2025 results reflect ongoing momentum and strong execution across all areas of our business,” said Mick Farrell, Chairman and CEO of ResMed. “We delivered 11% ...
How much a stock's price changes over time is a significant driver for most investors. Not only can price performance impact your portfolio, but it can help you compare investment results across ...
1mon
ResMed Inc.
View ResMed Inc. RMD stock quote prices, financial information, real-time forecasts, and company news from CNN.
ResMed went public in 1995 and has grown to a recent market value of nearly $38 billion. Its stock has averaged annual gains of 15.6% over the past 15 years, and 16.9% over the past 10. The stock's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results